Nat. Rev. Nephrol. doi: /nrneph

Slides:

Advertisements

Similar presentations

REMEDIAL II Renal Insufficiency Following Contrast Media Administration Trial II (REMEDIAL II): RenalGuard™ System In High-Risk Patients for Contrast-Induced.

Advertisements

Assessment and Diagnosis of Renal Dysfunction in the ICU

C. Chalklin, C. Colmont, A. Zaidi, J. Warden-Smith, E. Ablorsu

Copyright © 2015 by the American Osteopathic Association.

Renal Insufficiency After Contrast Media Administration Trial II (REMEDIAL II)Clinical Perspective by Carlo Briguori, Gabriella Visconti, Amelia Focaccio,

Figure 5 A layered approach to the follow-up of patients with acute kidney disease (AKD) Figure 5 | A layered approach to the follow-up of patients with.

Figure 4 Interplay between acute kidney injury (AKI),

Figure 6 Effects of adiponectin on podocyte function

Figure 6 Approach to drug management in patients with acute kidney disease (AKD) Figure 6 | Approach to drug management in patients with acute kidney disease.

Figure 4 Expression of coagulation protease receptors in renal cells

Figure 4 Interactions between adipose, the microbiome and kidney

Nat. Rev. Nephrol. doi: /nrneph

Figure 1 Mechanisms of kidney injury in the setting of obesity

Figure 2 Physiological changes in the renal system in pregnancy

Sheldon Chen Advances in Chronic Kidney Disease

Nat. Rev. Nephrol. doi: /nrneph

Contrast-Induced Acute Kidney Injury: Specialty-Specific Protocols for Interventional Radiology, Diagnostic Computed Tomography Radiology, and Interventional.

Figure 3 Putative actions of glucagon-like peptide 1 (GLP-1)

Figure 2 The network of chronic diseases and their mutual influences

Section 2: AKI Definition

Figure 1 The burden of chronic kidney disease (CKD)

Figure 2 Glomerular pathology in mice and humans with diabetic nephropathy Figure 2 | Glomerular pathology in mice and humans with diabetic nephropathy.

Nat. Rev. Nephrol. doi: /nrneph

Figure 2 Podocyte dysfunction is a common feature of renal injury

Blaithin A. McMahon, Patrick Thomas Murray Kidney International

Figure 2 Milestones in paediatric acute kidney injury (AKI) research

Figure 1 Sequential impact of diabetes platforms, genetic backgrounds and accelerators on albuminuria and kidney pathology in mouse models of diabetic.

Figure 1 Acute kidney injury and chronic kidney disease

Biomarkers in Nephrology: Core Curriculum 2013

Figure 2 The continuum of acute kidney injury (AKI),

Figure 4 Model of changes in the serum levels

Update on acute kidney injury after cardiac surgery

Nat. Rev. Nephrol. doi: /nrneph

Figure 6 Schematic of an analysis of a new biopsy

Nat. Rev. Nephrol. doi: /nrneph

Nat. Rev. Nephrol. doi: /nrneph

Nat. Rev. Nephrol. doi: /nrneph

Nat. Rev. Nephrol. doi: /nrneph

Figure 4 Differential protective effects of hydration

Figure 2 Determinants of renal contrast medium enrichment

Nat. Rev. Nephrol. doi: /nrneph

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Cardiol. doi: /nrcardio

Figure 3 Hypothetical trajectories of acute kidney disease (AKD)

Nat. Rev. Nephrol. doi: /nrneph

Figure 5 The nephron-centric model of renal transplant fibrosis based on the injury-related molecular events observed in biopsy samples in the first year.

Figure 6 Hypothetical effect of starting therapy for autosomal

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Volume 80, Issue 4, Pages (August 2011)

Figure 3 Serum phosphate level is associated with

Nat. Rev. Nephrol. doi: /nrneph

Figure 3 Regulation of TGF-β1/Smad signalling by microRNAs (miRs) in tissue fibrosis Figure 3 | Regulation of TGF-β1/Smad signalling by microRNAs (miRs)

Figure 1 The relationship between health fitness and pathogen load

Volume 78, Issue 12, Pages (December 2010)

Neutrophil gelatinase–associated lipocalin: A promising biomarker for detecting cardiac surgery–associated acute kidney injury Dinna N. Cruz, MD, Claudio.

Volume 84, Issue 4, Pages (October 2013)

The definition of acute kidney injury and its use in practice

Nat. Rev. Nephrol. doi: /nrneph

Figure 3 Pathophysiological events and preventive

Figure 3 Preventive strategies for CSA-AKI

Figure 4 The relationship between the time-dependent changes in the expression of immunoglobulin, mast cell, acute kidney injury (AKI), and fibrillar collagen.

Volume 73, Issue 5, Pages (March 2008)

Volume 79, Issue 10, Pages (May 2011)

Nat. Rev. Nephrol. doi: /nrneph

Receiver-operating characteristics analyses for predicting AKI progression or AKI progression with death. Receiver-operating characteristics analyses for.

Pediatric acute kidney injury: The use of the RIFLE criteria

Peter A. McCullough et al. JACC 2016;68:

Nat. Rev. Nephrol. doi: /nrneph

Volume 79, Issue 10, Pages (May 2011)

Diagnostic criteria for AKI

Presentation transcript:

Nat. Rev. Nephrol. doi:10.1038/nrneph.2016.196 Figure 1 Biomarkers dynamics in contrast-induced acute kidney injury (CIAKI) Figure 1 | Biomarkers dynamics in contrast-induced acute kidney injury (CIAKI). Modelling serum creatinine time courses120 revealed a specific pattern during CIAKI, which is characterized by a sharp decline in glomerular filtration rate (GFR) followed by slow GFR recovery. Typically, serum creatinine levels peak 2–3 days after contrast medium exposure16. The tubular specific biomarker neutrophil gelatinase-associated lipocalin (NGAL) is particularly sensitive for the early diagnosis of acute kidney injury (AKI), including CIAKI121, showing an increase as early as 6 h post-procedure122. Levels of cystatin C (CyC), an indicator of GFR, increase within 24 h after administration of contrast medium, thus constituting a further putative indicator of early stages of CIAKI29. Fähling, M. et al. (2017) Understanding and preventing contrast-induced acute kidney injury Nat. Rev. Nephrol. doi:10.1038/nrneph.2016.196